The actual cost to you or the insurance company may be different, depending upon insurance coverage. Bill Halter says: October 22, 2018 at 1:29 am Repatha, the new cholesterol-lowering “breakthrough,” explained. Doctors aren’t sure it’s worth it. In October 2018, Amgen announced that it is making Repatha available at a reduced list price of $5,850 per year. Injection would be given one every six months. MONDAY, March 26 (HealthDay News) -- Researchers report that injections of a novel "monoclonal antibody" lowered LDL cholesterol levels in patients with high cholesterol by as much as 72 percent.. If you have a low income, you may be eligible for financial assistance to help pay for Repatha from Amgen, the manufacturer. This much-hyped cholesterol drug costs $14,100 a year. A global trial led by Imperial College London has shown the 'gene-silencing' drug inclisiran to reduce 'bad' LDL cholesterol by 50 per cent. In Australia, the drug costs up to $900 a month for fortnightly injections, but a submission to include it on the Pharmaceutical Benefits Scheme will be known later this month. This 60 percent reduction from the medicine's … By Steven Reinberg HealthDay Reporter. If the LDL-C goal isn't reached despite the use of these therapies, adding a new type of high-cost cholesterol-lowering drug known as a PCSK9 inhibitor is recommended. Insurance only covers so much, I cannot imagine what is in this injection that creates a cost of $1,000 per month or $500 per shot. New Drugs May Beat Statins, But Price Is High. Repatha, inclisiran lowered cholesterol levels even further, but first costs about $14,000 a year to take